Dolby Laboratories (NYSE:DLB) Issues Q1 2027 Earnings Guidance

Dolby Laboratories (NYSE:DLB – Get Free Report) issued an update on its first quarter 2027 earnings guidance on Tuesday. The company provided earnings per share guidance of 0.410-0.560 for the period, compared to the consensus EPS estimate of 1.060. The company issued revenue guidance of $285.0 million-$305.0 million, compared to the consensus revenue estimate of $358.3 million. Dolby Laboratories also updated its FY 2027 guidance to 4.270-4.420 EPS.

Analyst Ratings Changes

A number of equities analysts have recently weighed in on the company. Zacks Research raised Dolby Laboratories from a “strong sell” rating to a “hold” rating in a research note on Friday, November 13th. Rosenblatt Securities decreased their price objective on Dolby Laboratories from $85.00 to $80.00 and set a “buy” rating on the stock in a research report on Monday. Wall Street Zen lowered shares of Dolby Laboratories from a “buy” rating to a “hold” rating in a report on Saturday, August 1st. Finally, Weiss Ratings upgraded Dolby Laboratories from a “sell (d+)” rating to a “hold (c-)” rating in a report on Wednesday, September 9th. Two analysts have rated the stock with a Buy rating and two have issued a Hold rating to the company. Based on data from MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and an average price target of $85.00.

Check Out Our Latest Analysis on DLB

Dolby Laboratories Trading Down 4.2%

Shares of DLB stock opened at $58.60 on Wednesday. The business’s fifty day simple moving average is $60.90 and its 200-day simple moving average is $59.40. The company has a market cap of $5.49 billion, a PE ratio of 24.94 and a beta of 0.79. Dolby Laboratories has a 12-month low of $48.26 and a 12-month high of $69.95.

Dolby Laboratories (NYSE:DLB – Get Free Report) last issued its earnings results on Tuesday, November 17th. The electronics maker reported $1.25 EPS for the quarter, beating analysts’ consensus estimates of $1.20 by $0.05. Dolby Laboratories had a return on equity of 11.08% and a net margin of 16.70%. The firm had revenue of $373.54 million for the quarter, compared to analyst estimates of $372.76 million. During the same quarter in the prior year, the firm earned $0.99 earnings per share. Dolby Laboratories’s revenue for the quarter was up 21.7% on a year-over-year basis. Dolby Laboratories has set its Q1 2027 guidance at 0.410-0.560 EPS and its FY 2027 guidance at 4.270-4.420 EPS. On average, equities analysts forecast that Dolby Laboratories will post 3.23 earnings per share for the current year.

Dolby Laboratories Increases Dividend

The business also recently declared a quarterly dividend, which will be paid on Wednesday, December 9th. Investors of record on Tuesday, December 1st will be issued a $0.39 dividend. This is a boost from Dolby Laboratories’s previous quarterly dividend of $0.36. This represents a $1.56 annualized dividend and a dividend yield of 2.7%. The ex-dividend date of this dividend is Tuesday, December 1st. Dolby Laboratories’s payout ratio is 61.28%.

Dolby Laboratories announced that its board has authorized a stock repurchase plan on Thursday, July 30th that permits the company to repurchase $350 million in outstanding shares. This repurchase authorization permits the electronics maker to reacquire up to 7% of its stock through open market purchases. Share repurchase plans are usually an indication that the company’s board believes its stock is undervalued.

Insider Transactions at Dolby Laboratories

In related news, SVP John Couling sold 7,667 shares of the stock in a transaction dated Thursday, October 1st. The stock was sold at an average price of $58.78, for a total transaction of $450,666.26. Following the transaction, the senior vice president owned 166,803 shares of the company’s stock, valued at approximately $9,804,680.34. This represents a 4.39% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, CAO Ryan Nicholson sold 1,183 shares of the stock in a transaction that occurred on Tuesday, August 25th. The stock was sold at an average price of $65.28, for a total transaction of $77,226.24. Following the sale, the chief accounting officer owned 34,453 shares in the company, valued at approximately $2,249,091.84. This trade represents a 3.32% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Insiders sold 16,517 shares of company stock worth $995,963 in the last ninety days. 37.93% of the stock is currently owned by corporate insiders.

Key Dolby Laboratories News

These are some of the DLB news items that stood out recently:

  • Positive Sentiment: Fiscal Q4 revenue rose 21.7% year over year to about $374 million, slightly above estimates, while EPS of $1.25 beat the roughly $1.19–$1.20 consensus and increased from $0.99 a year earlier. Dolby Laboratories Reports Fourth Quarter and Fiscal Year 2026 Financial Results
  • Positive Sentiment: Dolby raised its quarterly dividend 8.3%, from $0.36 to $0.39 per share, equivalent to $1.56 annually and a stated yield of 2.7%. The dividend is payable December 9 to shareholders of record December 1.
  • Negative Sentiment: Forward guidance was the main concern: Q1 fiscal 2027 revenue is forecast at $285–$305 million versus $358.3 million expected, and EPS at $0.41–$0.56 versus $1.06 expected. Fiscal 2027 revenue guidance of $1.4 billion also trails the $1.5 billion consensus. The full-year EPS range of $4.27–$4.42 is broadly in line with the $4.34 estimate, but the large Q1 shortfall may signal a softer near-term outlook. Dolby guidance and results

About Dolby Laboratories

(Get Free Report)

Dolby Laboratories, Inc. develops audio and imaging technologies used in entertainment and consumer electronics. Its offerings include Dolby Atmos immersive audio, Dolby Vision high-dynamic-range imaging, and technologies for encoding, delivering and reproducing sound and video. The company licenses its technologies to manufacturers and content businesses across areas such as film, television, streaming, gaming and mobile devices. Dolby also supports cinema experiences through technologies and services including Dolby Cinema.

Read More

Earnings History and Estimates for Dolby Laboratories (NYSE:DLB)

Receive News & Ratings for Dolby Laboratories Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Dolby Laboratories and related companies with MarketBeat.com's FREE daily email newsletter.